Preterm Birth and PROM Testing Market Analysis, Size, Growth, Share,Demand Outlook & Forecast to 2025
The global preterm birth and prom testing market size is expected to reach USD 1.3 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 1.8% during the forecast period. Rising incidence of preterm births, increasing geographical reach by market players, high demand for effective diagnosis of preterm births, and advanced drug delivery devices are expected to drive the market. Every year, approximately 15 million babies around the world are born before the 37th week of pregnancy and this number is expected to increase further. Around 1 million children die each year due to complications caused by preterm births. Premature Rupture of Membranes (PROM) causes about 4.5 million preterm births each year, worldwide. Globally, preterm birth is among the most frequent causes of death among neonates within the first month of life. Increasing average age of pregnant women (>35 years of age) has led to an increase in the risk of heath conditions such as high blood pressure and reduced blood flow to the placenta. These issues risk the health of both mother and unborn child and often result in preterm births or neonatal deaths. Even though traditional methods such as Nitrazine and Ferning test make it possible to obtain a negative predictive value (NPV), they have extremely poor positive predictive values for spontaneous deliver. The approval of PartaSure (Parsagen Diagnostics, Inc. and Qiagen) in April 2018 and other improved diagnostic test kits has introduced a highly efficacious yet cost-effective options for PROM testing in symptomatic patients. Preterm Birth and PROM Testing Market Report Highlights
Based on test type, the PAMG1 immunoassay segment is expected to witness lucrative growth over the forecast period driven by rapid uptake of these test kits in developed markets
Improved PROM diagnostic methods are increasingly replacing traditional standard-of-care tests (Ferning and Nitrazine), supported by their ease of use and high sensitivity
North America dominated the market with the largest share in 2017. Focus on early diagnosis of women’s health issues, along with improved awareness about preterm birth and PROM testing, are responsible for the dominance of this region
Strong unmet needs, rising awareness regarding maternal health, and uptake of improved diagnostic methods are expected to propel the growth of the preterm labor and PROM testing market
Some of the key players in the market are Qiagen, Hologic, Cooper Surgical, Abbott Laboratories, Medixbiochemica, Sera Prognostics, Biosynex, and IQ Products.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/preterm-birthprom-testing-market
Preterm Birth and PROM Testing Market Segmentation Grand View Research has segmented the global preterm birth and PROM testing market based on test type and region: Preterm Birth and PROM Testing Test Type Outlook (Revenue, USD Million, 2014 - 2025)
Pelvic exam
Ferning test
Nitazine test
Pooling (Speculum Exam)
Ultrasound
Uterine monitoring
IL-6
CRP
IL-1, IL-2, IL-8, TNF-a
CRH
AFP (Alpha fetoprotein)
fFN
PAMG-1 immunoassay
IGFBP test
Others
Get Sample of Report @ https://www.grandviewresearch.com/industry-analysis/preterm-birthprom-testing-market/request/rs1
Preterm Birth and PROM Testing Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America o
U.S.
o
Canada
Europe o
U.K.
o
Germany
o
France


o
Italy
o
Greece
o
Denmark
o
Spain
o
Austria
o
Switzerland
o
Russia
Asia Pacific o
India
o
China
o
Japan
o
South Korea
o
Australia
o
Singapore
o
Thailand
Latin America o
Brazil
o
Mexico
o

Argentina
Middle East & Africa o
South Africa
o
Saudi Arabia
o
UAE
o
Turkey
o
Iran
Table of Content Chapter 1 Methodology and Scope 1.1 Research Methodology 1.1.1 Information procurement 1.2 Information or Data Analysis 1.3 Research Scope and Assumptions 1.4 List to Data Sources Chapter 2 Executive Summary 2.1 Market Summary Chapter 3 Market Variables, Trends & Scope 3.1 Market Segmentation Chapter 4 Industry Outlook 4.1 Market Variable Analysis
4.1.1 Increasing average age of pregnant women leading to exponential rise in the number of preterm births 4.1.2 Improvement in point-of-care diagnostics 4.1.3 Social and economic factors 4.2 Market Restraint Analysis 4.2.1 Product recalls and adverse effects 4.2.2 High cost and unmet needs Continue……… About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com